World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease.

Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or ...

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the body, such as the bones or liver.

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.

Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer ...

Learn how a lung cancer cough might feel, and the multiple treatment options available.

The FDA has granted quick approval to sunvozertinib (sold as Zegfrovy) a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC).

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are already at increased risk of lung cancer.

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

Never-smoking women exposed to cooking oil fumes in Taiwan and Hong Kong have a higher risk of developing lung cancer, according to a systematic review.

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.